Should probiotics be tested on ex vivo organ culture models?

Katerina Tsilingiri, Maria Rescigno

Research output: Contribution to journalArticle

Abstract

The use of probiotic strains as nutritional supplements has been gaining ground in the last decade. As the mechanisms with which they modulate innate and adaptive immunity start to unravel, probiotics have repeatedly been suggested as potential treatment for a wide variety of diseases, including inflammatory bowel disease (IBD). However, even though the benefits of probiotic treatment for conditions like atopic dermatitis are well established, very limited clinical benefit has been obtained on IBD treatment. This could be due to the lack of suitable models on which to obtain valid pre-clinical data to select the most appropriate strain for a given condition. We recently described a newly developed model for the culture and apical stimulation of whole human intestinal mucosal explants. We showed that the tissue was only viable if incubated in an O(2) chamber, but it was possible to stimulate the tissue with bacteria in a conventional incubator. We used the new set-up to test three different Lactobacilli strains, none of which appeared to be benign on inflamed IBD mucosa.

Original languageEnglish
Pages (from-to)442-448
Number of pages7
JournalGut Microbes
Volume3
Issue number5
Publication statusPublished - Sep 2012

Fingerprint

Organ Culture Techniques
Probiotics
Inflammatory Bowel Diseases
Incubators
Lactobacillus
Adaptive Immunity
Atopic Dermatitis
Innate Immunity
Mucous Membrane
Bacteria

ASJC Scopus subject areas

  • Gastroenterology
  • Infectious Diseases
  • Microbiology (medical)
  • Microbiology

Cite this

Should probiotics be tested on ex vivo organ culture models? / Tsilingiri, Katerina; Rescigno, Maria.

In: Gut Microbes, Vol. 3, No. 5, 09.2012, p. 442-448.

Research output: Contribution to journalArticle

Tsilingiri, Katerina ; Rescigno, Maria. / Should probiotics be tested on ex vivo organ culture models?. In: Gut Microbes. 2012 ; Vol. 3, No. 5. pp. 442-448.
@article{5402539bcc1347b9a797353d25ee5285,
title = "Should probiotics be tested on ex vivo organ culture models?",
abstract = "The use of probiotic strains as nutritional supplements has been gaining ground in the last decade. As the mechanisms with which they modulate innate and adaptive immunity start to unravel, probiotics have repeatedly been suggested as potential treatment for a wide variety of diseases, including inflammatory bowel disease (IBD). However, even though the benefits of probiotic treatment for conditions like atopic dermatitis are well established, very limited clinical benefit has been obtained on IBD treatment. This could be due to the lack of suitable models on which to obtain valid pre-clinical data to select the most appropriate strain for a given condition. We recently described a newly developed model for the culture and apical stimulation of whole human intestinal mucosal explants. We showed that the tissue was only viable if incubated in an O(2) chamber, but it was possible to stimulate the tissue with bacteria in a conventional incubator. We used the new set-up to test three different Lactobacilli strains, none of which appeared to be benign on inflamed IBD mucosa.",
author = "Katerina Tsilingiri and Maria Rescigno",
year = "2012",
month = "9",
language = "English",
volume = "3",
pages = "442--448",
journal = "Gut Microbes",
issn = "1949-0976",
publisher = "Landes Bioscience",
number = "5",

}

TY - JOUR

T1 - Should probiotics be tested on ex vivo organ culture models?

AU - Tsilingiri, Katerina

AU - Rescigno, Maria

PY - 2012/9

Y1 - 2012/9

N2 - The use of probiotic strains as nutritional supplements has been gaining ground in the last decade. As the mechanisms with which they modulate innate and adaptive immunity start to unravel, probiotics have repeatedly been suggested as potential treatment for a wide variety of diseases, including inflammatory bowel disease (IBD). However, even though the benefits of probiotic treatment for conditions like atopic dermatitis are well established, very limited clinical benefit has been obtained on IBD treatment. This could be due to the lack of suitable models on which to obtain valid pre-clinical data to select the most appropriate strain for a given condition. We recently described a newly developed model for the culture and apical stimulation of whole human intestinal mucosal explants. We showed that the tissue was only viable if incubated in an O(2) chamber, but it was possible to stimulate the tissue with bacteria in a conventional incubator. We used the new set-up to test three different Lactobacilli strains, none of which appeared to be benign on inflamed IBD mucosa.

AB - The use of probiotic strains as nutritional supplements has been gaining ground in the last decade. As the mechanisms with which they modulate innate and adaptive immunity start to unravel, probiotics have repeatedly been suggested as potential treatment for a wide variety of diseases, including inflammatory bowel disease (IBD). However, even though the benefits of probiotic treatment for conditions like atopic dermatitis are well established, very limited clinical benefit has been obtained on IBD treatment. This could be due to the lack of suitable models on which to obtain valid pre-clinical data to select the most appropriate strain for a given condition. We recently described a newly developed model for the culture and apical stimulation of whole human intestinal mucosal explants. We showed that the tissue was only viable if incubated in an O(2) chamber, but it was possible to stimulate the tissue with bacteria in a conventional incubator. We used the new set-up to test three different Lactobacilli strains, none of which appeared to be benign on inflamed IBD mucosa.

UR - http://www.scopus.com/inward/record.url?scp=84874423399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874423399&partnerID=8YFLogxK

M3 - Article

C2 - 22713266

VL - 3

SP - 442

EP - 448

JO - Gut Microbes

JF - Gut Microbes

SN - 1949-0976

IS - 5

ER -